Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001615774-18-001748

Director acquired 2,850 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rhodes John B · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2017-05-27 Exercise or conversion : show line 1 in the form +1,125 15,970 D
2017-02-09 Exercise or conversion : show line 2 in the form +1,125 14,845 D
2016-02-25 Exercise or conversion : show line 3 in the form +600 8,720 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2017-05-27 Exercise or conversion : show line 4 in the form Restricted Stock Units −1,125 0 D
2017-02-09 Exercise or conversion : show line 5 in the form Restricted Stock Units −1,125 0 D
2016-02-25 Exercise or conversion : show line 6 in the form Restricted Stock Units −600 0 D
Loading xslF345X03/s109296_form4.xml…